ArticleJournal of the American Society of Nephrology : JASN2009

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

Sylvia P B Ramirez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.